Literature DB >> 8706594

Causes and problems of nonresponse or poor response to drugs.

P Salvà Lacombe1, J A García Vicente, J Costa Pagès, P Lucio Morselli.   

Abstract

The lack of (or poor) response to drugs has very important medical, social and economic consequences today. An unsatisfactory response to treatment implies not only a worsening or prolongation of the pathological state, but also prolonged hospitalisation, longer withdrawal from social and active life, and waste of community resources. Poor response to drugs has many and varied causes, among which 4 major categories can be identified: pharmacokinetic, cellular, genetic and medical. After a brief description of the terminology, the phenomena of tachyphylaxis, tolerance and drug resistance are analysed and critically described on the basis of the available evidence. Whenever possible, alternative or operative behaviours aimed at reducing the incidence of the above phenomena are commented on. On the question of medical causes, irrational prescriptions and poor compliance with the prescribed regimen stand as two major issues whose prevalence is worrying. In order to limit the waste of professional responsibility and economic resources, efforts aimed at reducing the present insufficiencies are needed at organisational and educational levels.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8706594     DOI: 10.2165/00003495-199651040-00004

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  120 in total

Review 1.  Drug therapy: The diagnosis and management of insomnia.

Authors:  J C Gillin; W F Byerley
Journal:  N Engl J Med       Date:  1990-01-25       Impact factor: 91.245

Review 2.  Mechanisms of nitrate tolerance: a review.

Authors:  R J Katz
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727

3.  Attenuation of nitrate effect during an intermittent treatment regimen and the time course of nitrate tolerance.

Authors:  M A James; M Papouchado; J V Jones
Journal:  Eur Heart J       Date:  1991-12       Impact factor: 29.983

Review 4.  Mechanisms of monooxygenase induction and inhibition.

Authors:  K J Netter
Journal:  Pharmacol Ther       Date:  1987       Impact factor: 12.310

5.  High efficiency coupling between beta-adrenergic receptors and cardiac contractility: direct evidence for "spare" beta-adrenergic receptors.

Authors:  J C Venter
Journal:  Mol Pharmacol       Date:  1979-09       Impact factor: 4.436

6.  Identification of the multidrug resistance-related membrane glycoprotein as an acceptor for calcium channel blockers.

Authors:  A R Safa; C J Glover; J L Sewell; M B Meyers; J L Biedler; R L Felsted
Journal:  J Biol Chem       Date:  1987-06-05       Impact factor: 5.157

7.  Hemodynamic effects of intermittent transdermal nitroglycerin in chronic congestive heart failure.

Authors:  N Sharpe; R Coxon; M Webster; R Luke
Journal:  Am J Cardiol       Date:  1987-04-01       Impact factor: 2.778

8.  The assessment and management of treatment-resistant schizophrenia in perspective.

Authors:  H Meltzer; H Hippius
Journal:  Eur Psychiatry       Date:  1995       Impact factor: 5.361

9.  Detection of P-glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance.

Authors:  D R Bell; J H Gerlach; N Kartner; R N Buick; V Ling
Journal:  J Clin Oncol       Date:  1985-03       Impact factor: 44.544

Review 10.  Regulation of cyclic GMP synthesis and the interactions with calcium.

Authors:  F Murad; S A Waldman; R R Fiscus; R M Rapoport
Journal:  J Cardiovasc Pharmacol       Date:  1986       Impact factor: 3.105

View more
  6 in total

1.  Effects of different intermittent peptide YY (3-36) dosing strategies on food intake, body weight, and adiposity in diet-induced obese rats.

Authors:  Roger D Reidelberger; Alvin C Haver; Prasanth K Chelikani; James L Buescher
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-06-11       Impact factor: 3.619

2.  Effects of leptin replacement alone and with exendin-4 on food intake and weight regain in weight-reduced diet-induced obese rats.

Authors:  Roger Reidelberger; Alvin Haver; Prasanth K Chelikani; Bettye Apenteng; Curtis Perriotte-Olson; Krista Anders; Sharalyn Steenson; James E Blevins
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-04-17       Impact factor: 4.310

3.  Protective effect of vanillic acid in hydrogen peroxide-induced oxidative stress in D.Mel-2 cell line.

Authors:  Shagufta Taqvi; Eijaz Ahmed Bhat; Nasreena Sajjad; Jamal S M Sabir; Aleem Qureshi; Irfan A Rather; Suriya Rehman
Journal:  Saudi J Biol Sci       Date:  2020-12-19       Impact factor: 4.219

4.  Rare genetic variability in human drug target genes modulates drug response and can guide precision medicine.

Authors:  Yitian Zhou; Gabriel Herras Arribas; Ainoleena Turku; Tuuli Jürgenson; Souren Mkrtchian; Kristi Krebs; Yi Wang; Barbora Svobodova; Lili Milani; Gunnar Schulte; Jan Korabecny; Stefano Gastaldello; Volker M Lauschke
Journal:  Sci Adv       Date:  2021-09-01       Impact factor: 14.136

Review 5.  Population pharmacogenomics: an update on ethnogeographic differences and opportunities for precision public health.

Authors:  Yitian Zhou; Volker M Lauschke
Journal:  Hum Genet       Date:  2021-10-15       Impact factor: 5.881

6.  Important role of kallikrein 6 for the development of keratinocyte proliferative resistance to topical glucocorticoids.

Authors:  Mari Kishibe; Gleb Baida; Pankaj Bhalla; Robert M Lavker; Bethanee Schlosser; Sin Iinuma; Shigetaka Yoshida; Joel T Dudley; Irina Budunova
Journal:  Oncotarget       Date:  2016-10-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.